Cash Flow

Balance Sheet | Cash Flow | Income Statement

Historical financial information is provided by Reuters. Axcan Pharma Inc. makes no representations or warranties with respect to the information contained herein and takes no responsibility for supplementing, updating, or correcting any such information.

Quarterly Cash Flow  View Annual Cash Flow

In Millions of U.S. Dollars (except for per share items)		Quarter Ending Dec 31, 2007	Quarter Ending Dec 31, 2007	Quarter Ending Sep 30, 2007
	Operating Activity
	Net Income	22.3	22.3	71.5
	Depreciation/Depletion	5.9	5.9	22.5
	Deferred Taxes	( 0.2)	( 0.2)	( 11.7)
	Non-Cash Items	1.0	1.0	11.7
	Changes in Working Capital	( 18.8)	( 18.8)	42.2
	TotalTotal Operating Activity	10.2	10.2	136.1
	Investing Activity
	Capital Expenditures	( 3.2)	( 3.2)	( 6.8)
	Other Investing Cash Flow Items, Total	123.8	123.8	( 12.6)
	TotalTotal Investing Activity	120.6	120.6	( 19.4)
	Financing Activity
	Financing Cash Flow Items	–	–	–
	Dividends Paid	–	–	–
	Issuance/Retirement of Stock, Net	0.2	0.2	7.3
	Issuance/Retirement of Debt, Net	( 0.1)	( 0.1)	( 0.7)
	TotalTotal Financing Activity	0.1	0.1	6.6
	Foreign Exchange Effects	0.4	0.4	0.6
	Total Cash Flow (Net Change in Cash)	131.2	131.2	123.8
	Cash Interest Paid (Indirect Format)	0.0	0.0	5.6
	Cash Taxes Paid (Indirect Format)	12.9	12.9	29.4

Home  |  Corporate Profile  |  Investor Relations  |  Events & Webcasts
Conferences  |  Products & Services  |  Export Operations  |  Axcan Worldwide